32-Carboxycyanocobalamin (Crude) is a cyanocobalamin derivative featuring a carboxylic acid substituent at the 32-position of the corrin macrocycle. This structural modification introduces an additional -COOH group adjacent to the cobalt-coordinated cyanide moiety, altering the electrostatic and steric properties relative to the parent vitamin B12 analog. The compound retains the characteristic corrin ring, 5,6-dimethylbenzimidazole nucleotide loop, and cobalt(III) coordination sphere, but the 32-carboxylic acid introduces a secondary ionization site, impacting solubility and chromatographic behavior. Synthetically, it arises as a side product during cyanocobalamin synthesis via nucleophilic substitution pathways. This impurity serves as an HPLC reference standard for quantifying process-related deviations in cyanocobalamin active pharmaceutical ingredient (API) batches.
